YANZU A HARSHE 22 DABAN DABAN. DANNA KASASHEN KWUSULUN HAGU "FURSSARA" DOMIN NEMAN NAKU!
Da Jeff J. Brown
Hoton da ke sama: Babban Sake saitin Plandemic na mulkin kama-karya yana kara duhu da duhu a rana. Linocut buga ta Sam Kerson (www.samkerson.com)
A nan, yana ɗaukar daƙiƙa guda kawai…
Shekaru goma sha shida a kan tituna, ina zaune da aiki tare da mutanen China , Jeff
Sauke manhajar SoundCloud (kuma a ƙasan wannan shafin), Brighteon, iVoox, RuVid , da kuma yadda ake tallata su a iTunes , Stitcher Radio da Reason.fm (hanyoyin haɗin da ke ƙasa),
Tashar Bidiyo ta Brighteon: https://www.brighteon.com/channels/jeffjbrown
MUHIMMAN SANARWA: techofascism yana nan! StumbleUpon (yanzu Mix) da Reddit sun cire ni. Facebook, Twitter da YouTube suna yi mani sharhi sosai. Lokaci ne kawai kafin su cire min dandamali kuma. Da fatan za a fara amfani da Brighteon don bidiyo na, sannan ku haɗa da ni ta wasu kafofin watsa labarun da aka jera a ƙasa, musamman VK, Telegram, Parler da WeChat, waɗanda ba sa cikin na'urar farfagandar MSM ta Yamma (BLPM).
Bidiyon Brighteon baya tacewa kuma yana goyan bayan magana kyauta, don haka da fatan za a yi rajista kuma ku kalli nan,
Sauti na SoundCloud:
Gabatarwa: wannan magana da Peter Daszak ya yi a cikin ashirin da goma sha biyar, wanda aka ruwaito a cikin National Academy of Press public Fabrairu 12th, 2016, kuma ina nakalto.
"Muna buƙatar ƙara fahimtar jama'a game da buƙatar matakan kariya daga cutar coronavirus kamar allurar riga-kafi ta pan coronavirus. Babban abin da ke haifar da hakan shi ne kafofin watsa labarai kuma tattalin arziki zai bi sahun masu suka. Muna buƙatar amfani da hakan don amfanin mu don gano ainihin matsalolin. Masu zuba jari za su mayar da martani idan suka ga riba a ƙarshen aikin ".
Cikakkun bayanan da aka rubuta daga gidan rediyon kasar Sin Rising…
Dr. Reiner Fuelmich
Dr. Reiner Fuelllmich- David, na yi nadama da na sa ka jira. Laifina ne. Shin har yanzu kana nan?
Dr. David E. Martin- Eh, ni ne.
Reiner- Kai, yayi kyau. Ina farin cikin sake ganinka.
Dauda- Ina farin cikin ganinka ma.
Reiner- Don haka ina ganin ya fi kyau idan ka gabatar da kanka. Na san kai ne shugaban Maqam International Innovation Risk Management, amma hakan ba ya gaya wa mutane da yawa abin da kake yi da gaske.
David- Eh, to, daga mahangar kamfanoni, tun daga karni na sha tara da casa'in da takwas, mun kasance mafi girman mai ba da lasisin kadarorin da ba a iya gani ba a duniya da ake amfani da su a fannin kuɗi a ƙasashe ɗari da sittin da takwas. Don haka a mafi yawan ƙasashen duniya akwai tsarin bayar da lasisi wanda ya haɗa da dukkan kundin dukkan haƙƙin mallaka, aikace-aikacen haƙƙin mallaka, tallafin tarayya, bayanan sayayya, bayanan gwamnati ta hanyar lantarki, da sauransu.
Muna da ikon ba kawai bin diddigin abin da ke faruwa da wanda ke da hannu a cikin abin da ke faruwa ba, amma muna sa ido kan jerin abubuwan buƙatu na ƙungiyoyi da daidaikun mutane da dama da kuma amfanin kanmu na kasuwanci. Domin kamar yadda wataƙila kuka sani, muna kula da daidaiton daidaiton duniya guda uku a cikin fihirisa, waɗanda su ne kan gaba wajen aiwatar da babban ma'auni da ma'auni na tsaka-tsaki a duk duniya.
Don haka sana’ar mu ita ce sanya ido kan sabbin abubuwa da ke faruwa a duniya musamman lura da tattalin arzikin wannan kirkire-kirkire. Matsayin da, ka sani, ana biyan bukatun kuɗi. Ana ruguza bukatun kamfanoni, da sauransu. Don haka kasuwancinmu shine kasuwancin kirkire-kirkire da kudaden sa. Amma a fili, daga mahangar wannan gabatarwar, kamar yadda kuka sani, mun sake nazarin haƙƙin mallaka sama da 4000 waɗanda aka bayar a kusa da coronavirus na SARS.
Kuma mun yi cikakken nazari game da kuɗin kuɗin duk magudin coronavirus wanda ya haifar da SARS a matsayin wani yanki na dangin beta coronavirus. Don haka abin da nake so in yi shi ne in ba ku taƙaitaccen bayani, tsarin lokaci cikin hikima, saboda ba za mu yi amfani da haƙƙin mallaka 4000 akan wannan tattaunawar ba. Amma na aika muku da ƙungiyar ku da takarda mai mahimmanci. An bayyana hakan a cikin bazara na 2020.
Reiner- Haka ne.
David- Wannan takarda, wadda kake da ita kuma za a iya saka ta a cikin bayanan jama'a, tana da matuƙar muhimmanci domin mun ɗauki jerin kwayoyin halittar da aka ruwaito, wanda aka ruwaito an ware shi a matsayin sabon coronavirus da ICTV, Kwamitin Ƙasa da Ƙasa kan Taxonomy of Viruses na Hukumar Lafiya ta Duniya ta nuna. Mun ɗauki ainihin jerin kwayoyin halittar da aka ruwaito sabbin abubuwa ne kuma muka sake duba su idan aka kwatanta da bayanan haƙƙin mallaka da ake da su a lokacin bazara na 2020.
Kuma abin da muka samu, kamar yadda zaku gani a cikin wannan rahoto, sama da shedu sama da ɗari da ashirin ne da aka haƙƙaƙe don ba da shawarar cewa ayyana wani labari na coronavirus da gaske gabaɗaya karya ce. Babu sabon coronavirus. Akwai gyare-gyare marasa ƙima sosai na jerin coronavirus waɗanda aka ɗora, amma babu wani sabon coronavirus da aka gano kwata-kwata. A gaskiya ma, mun sami bayanai a cikin bayanan haƙƙin mallaka na jerin abubuwan da aka danganta ga sabon abu zuwa haƙƙin mallaka waɗanda aka nema tun a farkon sha tara casa'in da tara.
Don haka ba wai kawai wannan ba labari bane, a zahiri ba labari bane kawai, ba labari bane sama da shekaru ashirin. Amma bari mu ɗauki ɗan gajeren lokaci kuma abin da zan yi shi ne zan kai ku cikin ɗan gajeren tafiya ta cikin filin haƙƙin mallaka don tabbatar da cewa mutane sun fahimci abin da ya faru. Amma kamar yadda kuka sani, har zuwa goma sha tara casa'in da tara, batun coronavirus Vis a VI aikin haƙƙin mallaka a kusa da coronavirus an yi amfani da shi na musamman ga kimiyyar dabbobi.
Alurar riga kafi na farko da aka taɓa yin haƙƙin mallaka na coronavirus hakika Pfizer ne ya nema. Aikace-aikacen don rigakafin farko na coronavirus, wanda shine musamman wannan furotin mai karu. Don haka ainihin abin da ake zargin mun yi gaggawar yin ƙirƙira. An shigar da aikace-aikacen farko ranar 28 ga Janairu, 2020 shekaru daya da suka gabata. Don haka ra'ayin cewa mun yi tuntuɓe a asirce a kan hanyar shiga tsakani kan alluran rigakafi ba kawai abin dariya ba ne, abin ban mamaki ne.
Domin Timothy Miller, Sharon na Albert, Paul Reed da Elaine Jones a ranar 20 ga Janairu, 2000, sun gabatar da abin da aka bayar a ƙarshe a matsayin ikon mallakar Amurka 6372224, wanda shine ƙwayar furotin mai karu, maganin rigakafi ga coronavirus na canine, wanda shine ainihin ɗayan nau'ikan coronavirus. Amma kamar yadda na ce, aikin farko har zuwa goma sha tara casa'in da tara ya fi mayar da hankali ne a fannin rigakafin dabbobi.
Dabbobin biyu da suka fi samun kulawa mai yiwuwa su ne aikin Ralph Barrack akan zomaye da cututtukan zuciya na zomo wanda ke da alaƙa da manyan matsaloli tsakanin masu kiwon zomo sannan kuma canine coronavirus a cikin aikin Pfizer don gano yadda ake haɓaka azaman furotin furotin da aka yi niyya ga ƴan takarar da ke haifar da tabbataccen shaidar da ta ce ba ra'ayin coronavirus na allurar ko ka'idar coronavirus kanta a matsayin pathogen na sha'awa.
Game da halayen sunadaran karu wani sabon abu ne kwata-kwata. A gaskiya ma, yana da shekaru ashirin da biyu bisa ga takardun haƙƙin mallaka. Abin da ya fi matsala kuma abin da a zahiri shine mafi girman matsalar shine Anthony Fauci da NIAID. An gano rashin lafiyar coronavirus don zama ɗan takara mai yuwuwar rigakafin cutar kanjamau, don haka SARS a zahiri ba ci gaba ba ne na dabi'a na gyare-gyaren ƙwayoyin cuta na coronavirus.
A gaskiya ma, musamman, a cikin sha tara casa'in da tara, Anthony Fauci ya ba da gudummawar bincike a Jami'ar North Carolina, Chapel Hill musamman don ƙirƙirar kuma ba za ku iya taimakawa ba sai dai ku yi kuka da abin da nake shirin karantawa, saboda wannan ya fito ne kai tsaye daga takardar izinin mallaka da aka shigar a ranar 19 ga Afrilu, 2002. Kuma kun ji kwanan wata daidai, 2002, wanda aka gina a cikin cutar coronavirus. An yi niyya na musamman ga huhu na mutum epithelium. A takaice dai, mun yi SARS.
Kuma mun ba da haƙƙin mallaka a ranar 19 ga Afrilu, 2002, kafin a taɓa samun bullar cutar a Asiya, wanda, kamar yadda kuka sani, ya biyo baya bayan watanni da yawa. Wannan haƙƙin mallaka da aka bayar a matsayin ikon mallakar Amurka bakwai zuwa bakwai tara uku biyu bakwai. Wannan alamar ta fito fili a cikin takamaiman takamaiman nau'in kwayoyin halittar gaskiyar cewa mun san cewa mai karɓar ace, yankin ACE guda biyu mai ɗaurewa, furotin S1 da sauran abubuwan abin da muka sani kamar yadda wannan cutar ba wai kawai injiniyoyi ba ne amma ana iya canza shi ta hanyar synthetically a cikin dakin gwaje-gwaje ta amfani da komai fiye da jerin jerin kwayoyin halitta, ɗaukar lambar kwamfuta tare da juya shi cikin ƙwayoyin cuta ko tsaka-tsaki.
Kuma an ba da kuɗin wannan fasahar ne kawai a farkon zamanin a matsayin hanyar da za mu iya amfani da coronavirus a zahiri a matsayin vector don rarraba rigakafin cutar kanjamau. Don haka sai ya kara muni. An bukaci mu ƙungiyara da mu sa ido kan cin zarafi da cin zarafin makamai masu guba a farkon kwanakin 2000. Za ku tuna abubuwan da suka faru a watan Satumba na 2001.
Kuma mun kasance wani ɓangare na binciken da ya haifar da binciken majalisar game da ba kawai asalin anthrax ba, har ma da abin da ba a saba da shi ba a kusa da maganin ciprofloxacin na Beyer, wanda shine amfani da miyagun ƙwayoyi a matsayin yiwuwar maganin cutar anthrax. Kuma a cikin faɗuwar shekara ta 2001, mun fara sa ido kan ɗimbin ƙwayoyin cuta na ƙwayoyin cuta da ƙwayoyin cuta waɗanda aka ba da izinin haƙƙin mallaka ta NIH, NIAID, USAMRIID, Hukumar Kula da Cututtuka ta Amurka, da wasu hukumomi da yawa na duniya waɗanda ke haɗin gwiwa da su.
Kuma damuwarmu ita ce ana ganin coronavirus a matsayin mai yuwuwar wakili mai yuwuwa don yuwuwar amfani da shi azaman maganin rigakafi, amma kuma a fili ana ɗaukarsa azaman ɗan takarar makami na halitta. Don haka rahotonmu na farko a bainar jama’a game da hakan ya faru ne kafin barkewar cutar SARS a ƙarshen 2001. Don haka za ku iya tunanin yadda na ji takaicin zama a nan bayan shekaru 20, kasancewar shekaru 20 a baya ya nuna cewa akwai matsala da ke kunno kai a sararin sama game da coronavirus.
Amma bayan fashewar da ake zargin kuma ni koyaushe zan ce barkewar cutar, saboda ina ganin yana da mahimmanci a gare mu mu fahimci cewa coronavirus a matsayin kwayar cuta mai yaduwa a cikin tsarin kwayar cutar da muke da ita a zahiri ba sabon abu bane ga yanayin ɗan adam kuma ba sabon abu bane a cikin shekaru ashirin da suka gabata. Haƙiƙa ya kasance wani ɓangare na jerin sunadaran da ke yawo na dogon lokaci.
Amma barkewar cutar da ake zargin ta faru a China a cikin 2002 zuwa 2003 ya haifar da matsala mai matukar wahala a watan Afrilu, 2003 da Cibiyar Kula da Cututtuka ta Amurka ta yi. Kuma wannan batu yana da mahimmancin mahimmanci don samun daidaito sosai, saboda ban da shigar da dukkanin jerin kwayoyin halitta akan abin da ya zama SARS coronavirus. Wanda a zahiri cin zarafi ne na Sashe na 101 na Code na Amurka talatin, ba za ku iya ba da izinin wani abu da ke faruwa a zahiri ba.
Sashe na lambar US talatin da biyar na ɗaya akan cin zarafi ɗaya shine lambar haƙƙin mallaka 7220852. Yanzu, wannan takardar shaidar tana da jerin haƙƙin mallaka masu alaƙa da ita. Waɗannan su ne aikace-aikacen mu na haƙƙin mallaka waɗanda aka karye saboda suna da nau'ikan jigogi masu yawa. Amma waɗannan sun haɗa da US Patent 46492703 P, wanda shine ainihin ƙima mai ban sha'awa. The US Patent 776521 wato 7776521. Waɗannan haƙƙoƙin ba wai kawai sun rufe jerin kwayoyin halittar SARS coronavirus ba, har ma sun rufe hanyoyin gano shi ta amfani da rPCR.
Yanzu, dalilin da ya sa hakan ke da matsala shi ne, idan a zahiri ku biyu ke da haƙƙin mallaka a kan kwayar halittar kanta kuma kun mallaki haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin gano shi, kuna da fa'idar wayo ta yadda za ku iya sarrafa kashi ɗari bisa ɗari na tabbatar da ba wai ita kanta kwayar cutar ba, har ma da gano ta, ma'ana kuna da cikakkiyar kulawar kimiyya da saƙo. Kuma wannan takardar shaidar da CDC ta nema an yi zargin cewa ƙungiyar hulɗar jama'a ce ta ba da hujjar cewa ana neman kowa da kowa don samun damar yin bincike kan coronavirus.
Matsalolin da ke tattare da wannan magana ita ce karya. Kuma dalilin da ya sa ya zama karya shi ne saboda ofishin mallakar mallaka, ba sau ɗaya ba amma sau biyu ya ki amincewa da haƙƙin mallaka na jerin kwayoyin halitta a matsayin wanda ba shi da haƙƙin mallaka saboda jerin kwayoyin halittar sun riga sun kasance a cikin jama'a. A wasu kalmomi, kafin CDC yin rajistar haƙƙin mallaka. Ofishin haƙƙin mallaka ya samo asali kashi casa'in da tara tara na kashi tara tare da riga-kafi na coronavirus da aka yi rikodin a cikin jama'a da kuma kan kin amincewa da mai binciken haƙƙin mallaka.
Kuma bayan da ya biya tarar roko a cikin 2006 da 2007, CDC overrode patent ofishin ne kin amincewa da haƙƙin mallaka da kuma kyakkyawan a 2007 samu patent a kan SARS coronavirus. Ko da yake duk wata sanarwar jama'a da CDC ta yi da ta ce hakan yana da amfani ga jama'a karya ne ta hanyar cin hancin da suka biya ga ofishin haƙƙin mallaka. Wannan ba wani abu bane mai dabara. Kuma abin da ya fi muni, sun biya ƙarin kuɗi don ɓoye aikace-aikacen su a sirri.
Lokaci na ƙarshe da na bincika, idan kuna ƙoƙarin samar da bayanai don binciken jama'a, ba za ku biya kuɗi don kiyaye bayanan sirri ba. Da ma na iya yin duk wani abu da na ce kawai, amma duk wannan yana samuwa a cikin kundin tarihin mallaka na jama'a, wanda kowane memba na jama'a zai iya dubawa, da kuma mai biyan kuɗi, kamar yadda ake kira da shi, Ofishin Ba da Lamuni na Amurka yana da ba kawai shaida ba, amma ainihin takardun da nake da su a hannuna.
Yanzu, wannan yana da matukar muhimmanci. Yana da matukar mahimmanci saboda masu binciken gaskiya sun sha bayyana cewa sabon coronavirus da aka sanya a matsayin sars-cov-2 hakika ya bambanta da takardar shaidar CDC. Kuma ga duka biyun kwayoyin halitta da matsalar haƙƙin mallaka. Idan ka kalli jerin kwayoyin halittar da CDC ta shigar a shekarar 2003, kuma a cikin 2005 sannan kuma a shekara ta 2006, abin da ka samu shine ainihi a wani wuri tsakanin kashi tamanin da tara zuwa casa'in da tara cikin dari na jerin abubuwan da aka gano a cikin abin da ake kira novel subclass na sars-cov-2.
Abin da muka sani shine ainihin sunan SARS coronavirus, wanda shine ainihin dangin beta coronavirus. Kuma ƙaramin juzu'in da ake kira sars-cov-2 dole ne ya mamaye ta ta fuskar haraji, ba za ku iya samun sunan Saar akan wani abu ba tare da kasancewar sa na farko ba. Don haka binciken gaskiyar da aka yi, yana mai cewa ko ta yaya wata CDC ba ta da wata alaƙa da wannan takamaiman haƙƙin mallaka ko kuma wannan cuta ta musamman ta wuce amincin ainihin jerin abubuwan da aka buga.
Hakanan ya wuce sahihanci idan aka zo batun harajin ICTV, saboda a fili ya bayyana cewa wannan a zahiri wani yanki ne na clade da ake kira SARS coronavirus. Yanzu abin da ke da mahimmanci shi ne ranar ashirin da takwas ga Afrilu kuma ku saurari kwanan wata da kyau, domin wannan kwanan wata yana da matsala.
Kwanaki uku bayan CDC ta gabatar da takardar shaidar ta SARS coronavirus a cikin dubu biyu da uku, bayan kwana uku, Sequoia Pharmaceuticals, wani kamfani da aka kafa a Maryland, Sequoia Pharmaceuticals, a ranar 20 ga Afrilu 2003, ya shigar da takardar haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin ƙwayoyin cuta na jiyya da sarrafa kamuwa da cututtukan coronavirus. CDC ta gabatar da kwanaki uku a baya sannan kuma ana samun jiyya bayan kwana uku. Yanzu, kawai riƙe wannan tunanin na daƙiƙa guda.
Reiner- Wanene Sequoia Pharmaceuticals?
David- To, ga shi nan. Wannan tambaya ce mai kyau, domin Sequoia Pharmaceuticals da kuma Ambling Pharmaceuticals sun zama mallakar Pfizer, Crucell da Johnson da Johnson.
Reiner - To.
Dauda- Don haka ka yi wa kanka tambaya mai sauƙi, ta yaya mutum zai sami haƙƙin mallaka kan magani ga wani abu da aka ƙirƙiro kwana uku da suka gabata?
Reiner- Haka ne.
David- Takardar izinin mallakar da ake magana a kai. Takardar izinin mallakar mallaka ta 28 ga Afrilu, dubu biyu da uku 7151163 da aka bayar ga Sequoia Pharmaceuticals tana da wata matsala. Matsalar ita ce an bayar da ita kuma an buga ta kafin a amince da haƙƙin mallakar CDC kan cutar coronavirus. Don haka matakin da za a iya sanin bayanan ta kowace hanya banda bayanan sirri tsakanin waɗannan ɓangarorin ba sifili ba ne.
Ba zai yuwu a zahiri ku ba da izinin abin da ke haifar da abin da ba a buga shi ba saboda CDC ta biya don ɓoye shi. Wannan, abokaina, shine ma'anar maƙarƙashiya, cin zarafi da haɗa baki. Wannan ba ka'ida ba ce. Wannan shaida ce. Ba za ku iya samun bayanai ba. A nan gaba, a cikin tsari na magani ga wani abu da ba ya wanzu.
Reiner- Wannan zai iya zama shari'ar RICO, a ƙarshe,
David- Wannan dai shari'ar RICO ce. Wannan ita ce za ta iya bullowa a ciki. Shari'ar RICO ce. Kuma tsarin RICO, wanda aka kafa a watan Afrilun 2003 don cutar coronavirus ta farko, an yi shi daidai da jadawalin. Idan muka ga sars-cov-2 ya bayyana, lokacin da Moderna ke samun jerin furotin mai yawa ta waya daga Cibiyar Binciken Allurar Rigakafi. A NIAID, kafin a fassara sabon ƙabilar Sub-clan. Ta yaya kuke magance wani abu kafin ku sami abin?
Reiner- Kai, dole ne in fassara wannan. Wannan ba za ka iya ƙirƙira wannan ba. Tabbas a'a.
Dauda- Haka ne, zai ƙara ta'azzara a nan.
Reiner- Kai, a'a, ba zai iya ƙara muni ba.
David- Oh, haka yake. A ranar 5 ga Yuni, 2008, wanda muhimmin rana ce domin a zahiri lokacin ne DARPA, Shirin Bincike Mai Ci Gaba a Tsaro a Amurka, ya nuna sha'awar cutar coronavirus a matsayin makamin halittu. 5 ga Yuni, 2008, wanda kamar yadda kuka sani, yanzu wani ɓangare ne na Sanofi ya shigar da jerin haƙƙin mallaka waɗanda suka yi niyya musamman ga abin da aka gaya mana shine sabon fasalin cutar sars-cov-2, kuma kun ji abin da na faɗa. Wannan shine karo na biyar ga Yuni, dubu biyu da takwas.
Reiner- Me suka samu?
Dauda- musamman sun yi niyya ga abin da ake kira wurin yankewar poly basic don sars-cov-2, sabon Spike Protein, da kuma matsayin yankin ɗaure masu karɓar 2, wanda ake zargin sabon abu ne ga sars-cov-2. Kuma duk wannan an ba da haƙƙin mallaka a ranar 5 ga Yuni 2008, kuma an ba da waɗannan haƙƙin mallaka a jere tsakanin Nuwamba 2014 na 2015 wanda shine haƙƙin mallaka na Amurka tara ɗaya tara uku bakwai takwas sifili, don haka wannan ya fito bayan an sami dakatarwar aiki.
Wancan ya zo ne bayan barkewar cutar MERS a Gabas ta Tsakiya, amma abin da kuka samu shi ne, a cikin 2016, 2017, 2019 jerin haƙƙin mallaka duk ba wai kawai nau'in RNA ba ne, har ma da ƙananan abubuwan da ke cikin nau'in kwayar halitta duk an ba su ga Ambling da Sanofi. Sannan muna da Crucell. Muna da Rubik's Therapeutics.
Muna da Kamfanin Kula da Lafiya na Yara, muna da wasu marasa adadi waɗanda suka haɗa da Jami'ar Ludwig Maximilian da ke München, Kamfanin Kimiyya na Protein, Cibiyar Ciwon daji ta Dana Farber, Jami'ar Iowa, Jami'ar Hong Kong, Cibiyar Halittar Halittar Dan Adam ta kasar Sin da ke Shanghai, duk suna bayyana a cikin takardun haƙƙin mallaka wanda ya kasance daga dubu biyu da takwas zuwa ashirin da bakwai.
Duk wani sifa da aka yi zargin an buga shi ta musamman ta hanyar ɗaba'ar magana guda ɗaya, sabon littafin Bat Coronavirus ya bayyana, faɗi, shigar da dabi'a a baki ɗaya zuwa biyu na rukunin furotin mai karu da yiwuwar sake haɗuwa da asalin cutar sars-cov-2, takardar da aka saba amfani da ita don gano ƙwayar cuta. Abin takaici, idan da gaske ka ɗauki abin da suka bayar da rahoton zama labari, za ka sami Patent's Issued saba'in da uku tsakanin 2008 da 2019, waɗanda ke da abubuwan da ake zargin labari ne a cikin sars-cov-2.
Musamman kamar yadda yake da alaƙa da ainihin tushen cleavage tushen yanki mai ɗaure mai karɓa da kuma furotin da aka ɗora, don haka abubuwan ban mamaki na asibiti na musamman na asibiti, masu yaduwa. Ka san inda zan dosa da wannan? ko? Ba a samu barkewar cutar SARS ba. Domin mun tsara dukkan abubuwan da ke cikin wannan.
Kuma a shekarar 2016, takardar da aka ba da tallafi yayin samun aikin dakatar da aiki wanda ya ce SARS coronavirus ya shirya don fitowar ɗan adam. Babu wanda ya rubuta sai Ralph Baric. Ba wai kawai an shirya don fitowar ɗan adam ba, amma an ba shi izinin yin amfani da kasuwanci. Sau saba'in da uku
Reiner- Shin ba Ralph Barack ba ne, ina tsammanin na ga wani faifan bidiyo tare da shi yana ba da jawabi inda ya faɗa wa masu sauraro a sarari cewa za ku iya samun kuɗi mai yawa da wannan.
David- Eh, za ka iya. Kuma ya sami kuɗi mai yawa wajen yin wannan.
Reiner- Oh.
David- Don haka ga waɗanda ke son rayuwa cikin ruɗani cewa ko ta yaya ko wata hanya ƙarshen labarin ne. Na shirya don babban takaici domin wani ya san wani abu a cikin 2015 da 2016, wanda ya haifar da furucin da na fi so game da wannan annoba gaba ɗaya. Kuma ta wannan hanyar, ba ni da kyau. Furucin da na fi so game da wannan annoba shine furucin da aka yi a 2015. Na Peter Daszak Wannan furucin da Peter ya yi a cikin shekaru ashirin da biyar ya ruwaito a cikin mujallar National Academy of Press a ranar 12 ga Fabrairu, 2016, kuma ina ambato.
"Muna buƙatar ƙara fahimtar jama'a game da buƙatar hanyoyin magance magunguna irin su pan coronavirus maganin rigakafi. Babban direba shine kafofin watsa labaru kuma tattalin arziki za su bi ka'idar. Muna buƙatar amfani da wannan don amfaninmu don samun ainihin al'amurra. Masu zuba jari za su mayar da martani idan sun ga riba a karshen tsarin ".
Viviane Fischer - Abin mamaki ne ƙwarai domin na yi tunanin hakan
Dauda- Bari in sake karanta wannan, kawai saboda ban san ko zan iya ɓacewa a fassarar ba. Don haka bari in ci gaba da karanta shi a hankali.
Reiner- Haka ne.
David- Kuma kamar yadda Amurkawa ke son yin magana da masu sauraro masu harsuna da yawa, wataƙila ya kamata in faɗi da ƙarfi.
Reiner- Ba zan yi ba.
David- Muna buƙatar ƙara fahimtar jama'a game da buƙatar matakan kariya daga cutar coronavirus kamar allurar riga-kafi ta pan coronavirus. Babban abin da ke haifar da hakan shi ne kafofin watsa labarai kuma tattalin arziki zai biyo bayan wannan hayaniyar. Muna buƙatar amfani da wannan hayaniyar don amfanin mu don isa ga ainihin matsalolin, masu zuba jari za su mayar da martani idan suka ga riba a ƙarshen aikin.
Viviane -Hakika ina nufin, Peter Dashi, shin ba shi ne wanda ya yi ba?
Reiner - A'a, ba, ba. Peter Daszak,
David- Peter Daszak , shugaban EcoHealth Alliance
Reiner- Peter Daszak mutumin kirki ne.
Viviane - Haka ne, na yi kawai.
David- Peter Daszak mutumin da ke tabbatar da wannan ka'idar da ba ta shafi dakin gwaje-gwaje na kasar Sin ba saboda babu ɓullar cutar a dakin gwaje-gwaje. Wannan wani shiri ne na amfani da sunadaran spike proteins don allurar mutane don su kamu da cutar coronavirus. Wannan ba shi da alaƙa da wani cuta da aka fitar. Kuma duk wani bincike da aka yi don tabbatar da ɓullar cutar a dakin gwaje-gwaje, to lallai ɓullar cutar ja ce.
Viviane- Kuma babu wani abu sabo a cikin wannan.
David- Babu komai sifili. Haƙƙoƙin mallaka saba'in da uku akan komai sabon abu ne a asibiti, saba'in da uku duk an bayar kafin ashirin da tara, kuma zan ba ku mafi girman abin da ya faru don tabbatar da cewa wannan ba sakin komai bane saboda haƙƙoƙin mallaka bakwai biyu bakwai tara uku biyu bakwai. Haƙƙin mallaka akan yanayin sake haɗawa na wannan LUNG da ke kai hari ga cutar coronavirus an canja shi ta hanyar asiri daga Jami'ar North Carolina, Chapel Hill zuwa Cibiyoyin Lafiya na Ƙasa a cikin ashirin da takwas da goma sha takwas.
Yanzu, ga matsalar wannan. A karkashin Bayh Dole, gwamnatin Amurka ta riga ta sami abin da ake kira tanadin tafiya daidai. Wannan yana nufin idan an biya gwamnatin Amurka kuɗi don bincike, suna da damar cin gajiyar wannan binciken bisa ga buƙatarsu ko kuma yadda suke so. Don haka bayyana dalilin da ya sa a cikin ashirin da goma sha bakwai da ashirin da takwas, ba zato ba tsammani hukumomin kiwon lafiya na kasa dole ne su mallaki takardar shaidar cewa sun riga sun sami 'yancin gudanar da Jami'ar North Carolina, Chapel Hill.
Kuma ta yaya suka buƙaci shigar da takardar shaidar gyara don tabbatar da cewa an aiwatar da shi bisa doka? Domin an sami kuskuren rubutu a cikin batun bayar da tallafi a farkon rubutawa, don haka suna buƙatar tabbatar da cewa ba wai kawai sun sami daidai ba, amma suna buƙatar tabbatar da cewa kowane kuskuren rubutu da ke cikin takardar shaidar ya kasance daidai akan takardar shaidar guda ɗaya da ake buƙata don haɓaka hurumin binciken allurar rigakafin, wanda aka raba tsakanin Jami'ar North Carolina Chapel Hill a watan Nuwamba na goma sha tara, lokacin da UNIDC na ashirin da tara a cikin watan Nuwamba na 29 da Moderna Hill. Moderna ya fara aiwatar da tsarin rigakafin furotin. Wata guda kafin barkewar cutar ta faru.
Reiner- Kana da dukkan shaidun, ko ba haka ba?
Dauda - Haka ne.
Reiner- Don haka komai game da kuɗi ne.
David- Kullum batun kuɗi ne, kuma kawai don amsa tambayar da aka yi ɗan lokaci kaɗan, an rubuta rubutun wannan a farkon Janairu shida, 2004.
Reiner - Janairu shida, 2004, wa ya rubuta rubutun?
David- Merck da taron sun kira SARS da ta'addancin halittu.
Reiner- Haba,
David- Ta'addancin halittu, cututtukan da ke tasowa, magungunan kashe ƙwayoyin cuta, magungunan warkarwa da kuma masu daidaita garkuwar jiki. Merck ya gabatar da ra'ayin abin da suka kira sabon al'ada. Sunan da ya dace sabon al'ada, wanda shine harshen da ya zama kamfen ɗin da Hukumar Lafiya ta Duniya ta amince da shi, Hukumar Kula da Shirye-shiryen Duniya, wacce ita ce hukumar da darektan Cibiyar Kula da Cututtuka ta China, Dakta Elias na Gidauniyar Gates da Anthony Fauci suka kafa a kan wannan kwamitin gudanarwa.
Amma farkon gabatarwar sabon yaƙin neman zaɓe na yau da kullun, wanda shine game da samun mutane don karɓar allurar rigakafin mura ta duniya PAN coronavirus, an karɓi haƙiƙanin Janairu shida, 2004. Don haka ya daɗe sosai. Ba zan yi la'akari da wasu abubuwa da yawa ba in ban da cewa a bayyane yake cewa Merck ya san cewa ku yi hakuri Moderna ya san cewa za a sanya shi a gaban layin dangane da ci gaban rigakafin a watan Maris na 2019.
Kuma wannan wata rana ce mai matukar muhimmanci domin a cikin watan Maris na goma sha tara, bisa dalilan da ba a bayyana su ba, kwatsam sai suka yi gyaran fuska ga wasu takardu da aka yi watsi da su, wanda hakan lamari ne mai ban mamaki. Amma sun yi gyara da dama na fastocin haƙƙin mallaka don yin magana ta musamman ga sakin ganganci ko na ganganci. Na tuba. Wa'adin su da gangan sakin coronavirus.
Don haka a cikin Maris, sun gyara aikace-aikacen patent guda hudu da suka gaza don fara aiwatar da ci gaban rigakafin cutar coronavirus, kuma sun fara tunkarar wata babbar matsala da suke da ita, wacce ta dogara da fasahar da ba su mallaki kamfanonin Kanada Arbutus Pharmaceuticals da Equitas Pharmaceuticals a zahiri sun mallaki takardar shaidar ambulan lipid nanoparticle da ake buƙata don isar da allurar MRNA.
Kuma an ba da waɗannan takaddun haƙƙin a cikin Kanada da Amurka sannan a duk faɗin duniya da makamantan ikonsu na duniya, Moderna sun san cewa ba su mallaki haƙƙin ba kuma sun fara ƙoƙarin yin shawarwari tare da Arbutus da Equitas don samun ƙudurin fasahar ƙira ta lipid nanoparticle da ke akwai don sanya shi cikin maganin rigakafi.
Kuma mun sani, kamar yadda na yi magana a baya, cewa a watan Nuwamba, sun shiga wani bincike da hadin gwiwa bincike da ci gaban yarjejeniya tare da UNC Chapel Hill game da samun furotin mai karu da za a saka a cikin nanoparticle na lipid domin a zahiri suna da rigakafin ɗan takara kafin mu sami cutar da ake zargin cewa tana gudana.
Abin da ya sa wannan labarin ya fi zama matsala fiye da yadda ake bayyana kansa shi ne, mun san cewa daga 2016 har zuwa dubu biyu da sha tara a kowane taro na Hukumar Ba da Shawara ta NIAID, Anthony Fauci ya koka da yadda ya kasa samun hanyar da zai sa mutane su karbi maganin mura na duniya, wanda shi ne abin da ya fi so.
Yana kokarin sa jama'a su shiga cikin wannan tsari. Kuma abin da ya bayyana sosai tare da Peter Daszak, EcoHealth Alliance, UNC, Chapel Hill da sauransu, sannan kuma musamman ta watan Maris na dubu goma sha tara, a cikin gyare-gyaren patent filings na Moderna, mun ga cewa akwai wani, Epiphany cewa ya ce, abin da idan akwai wani hatsari ko wani ganganci saki na numfashi pathogen, da kuma abin da ya sa wannan ne musamman kalmar "Rivers" a cikin Littafi Mai-Tsarki. yanayin da Hukumar Lafiya ta Duniya ta haɗa a watan Satumba na ashirin da sha tara.
Don haka watanni kafin a sami wani wanda ake zargi da cutar wanda ya ce muna buƙatar samun haɗin gwiwar ƙwarewar duniya game da sakin ƙwayoyin cuta na numfashi. Wanda ya zuwa ranar 20 ga Satumba, 20, dole ne ya samar da damar gudanar da huldar jama'a, kula da jama'a da kuma yarda da dokar rigakafin ta duniya. Wannan shine Satumba na ashirin da sha tara, kuma an rubuta yaren sakin ganganci na cututtukan numfashi a cikin yanayin da ya kamata a kammala maganar nan da Satumba 2020.
Dr. Wolfgang Wodarg- Wannan rubutu ne daga wannan mummunan labari kuma yana jagorantar wannan kwamiti, ko ba haka ba?
David- To, wannan ita ce sanarwar da Hukumar Kula da Shirye-shirye ta Duniya ta fitar. Akwai mutane da dama da suka karɓi yabo sannan suka ja da baya saboda hakan. Amma eh, gaskiya ne.
Wolfgang- Shin ina da gaskiya idan na ce haka kuma mai karɓar ACTU wanda aka riga aka bayyana a cikin haƙƙin mallaka kafin 2019?
Dauda- Eh. Muna da haƙƙin mallaka guda ɗari da sha bakwai, musamman tsarin da ke kai hari ga masu karɓar ƙwayoyin cuta na SARS.
Wolfgang- – Don haka saboda koyaushe suna cewa wannan sabon abu ne tare da kwayar cutar
David- Yanzu ba sabon abu bane kuma bai ma zama sabon abu ba. Yana cikin wallafe-wallafe tun daga shekarar 2008 a cikin tarurrukan makamai da aka gudanar a Slovenia, a Turai, a duk faɗin Turai da kuma duk faɗin kayayyakin more rayuwa na DARPA. Mun san game da hakan tun daga shekarar 2013, keɓewa da faɗaɗa shi.
Viviane- Kuma wannan gyaran da Merck ya yi wa wannan binciken, aikace-aikacen haƙƙin mallaka da aka ƙi, shin kawai game da gaskiyar cewa kamar da gangan ne, kun sani, kamar sanya wani abu a cikin muhalli ko sun ƙara wani abu?
David- To, waɗannan aikace-aikacen haƙƙin mallaka guda huɗu ne da suka gaza waɗanda aka farfaɗo da su a watan Maris na dubu biyu da sha tara. Kuma Moderna ce. Na yi kuskure wajen magana. Na yi magana game da Merck. Moderna ce. Kuma na yi ƙoƙarin gyara hakan. Yi haƙuri da cewa hakan bai faru ba. Amma aikace-aikacen haƙƙin mallaka na Moderna da aka gyara a watan Maris na dubu biyu da sha tara don haɗawa da sakin harshen ƙwayoyin cuta na numfashi da gangan.
Viviane - Wa ya ce ba a ƙi shi ba saboda wani dalili, amma ba wai kawai suna zaune a wurin ba ne kawai.
Dauda- A'a, suna yin aiki iri ɗaya da sauran kamfanonin magunguna inda suke yin aikace-aikacen da ba sa lalacewa kuma suna ci gaba da gyara aikace-aikacen don jin daɗin kwanakin farko da ake da su. Amma shi ya sa dole ne ku koma ku duba gyaran bayanan aikace-aikacen don gano lokacin da aka sanya ainihin yaren gyara. Amma ina nufin, gaskiyar magana ita ce kuma kamar yadda na ce, ba zan yi la'akari da duk bayanan haƙƙin mallaka ba.
Amma duk wani ikirari cewa wannan cuta ta musamman ce ta musamman ko kuma labari ya rabu akan ainihin jerin kwayoyin halitta, waɗanda aka buga a cikin rikodin haƙƙin mallaka sannan kuma da yawa sun lalace a cikin gaskiyar cewa muna da Peter Daszak da kansa yana faɗin cewa dole ne mu ƙirƙiri buƙatun jama'a don samun jama'a su karɓi maganin rigakafin cutar PAN coronavirus.
Kuma abin da ya sa hakan ya fi ban dariya shi ne gaskiyar cewa, kamar yadda muka sani, Hukumar Lafiya ta Duniya ta ayyana coronavirus a matsayin, ka sani, irin matattun sha'awa. Ina nufin, sun ce mun kawar da coronavirus abin damuwa ne. Don haka me ya sa muka kawar da shi a 2007 da 2008, me ya sa muka fara kashe biliyoyin daloli a duniya don yin rigakafin wani abu da aka kawar da shi ta hanyar shela a cikin dubu biyu da takwas, ka sani, irin nau'in ya fada cikin yanki na rashin imani, a ce akalla.
Reiner- Amma shin hakan ba yana nufin idan kai idan ka ɗauki dukkan shaidun to wannan kayan aiki ne na cutar coronavirus da alluran rigakafi. Wannan kayan aiki ne kuma sha'awar DARPA wajen ƙirƙirar makamin halitta daga wannan. Wannan kayan aiki ne na duk wani abu da ya shafi wannan, gami da sarrafa jama'a, misali.
Dauda- To, ku saurara, dole ne mu daina faɗawa cikin labaran da suka fi muhimmanci a cikin jerin tambayoyinmu, domin gaskiyar magana ita ce an ɗauke wannan a matsayin makamin halitta mai sauƙin lalacewa. Babu shakka cewa nan da shekarar 2005, babu shakka makamin zaɓi ne. Kuma ruɗin da muke ci gaba da ganin mutane masu kyakkyawar niyya sun makale a ciki shine tattaunawa game da ko muna da allurar riga-kafi don ƙwayar cuta. Gaskiyar magana ita ce, ba mu ba ne.
Muna allurar furotin mai kauri MRNA Sekra da jerin RNA, wanda shine simintin kwamfuta. Ba a samo shi daga yanayi ba. Kwamfuta ce ta simulation na jerin abubuwan da aka sani kuma an ba da izini ga shekaru. Kuma abin da muka sani shi ne cewa jerin, kamar yadda aka ruwaito, ana ba da rahoto a cikin abubuwa kamar, ka sani, tattaunawar wayar da aka dogara da ita da aka yi tsakanin Moderna da Cibiyar Nazarin Alurar riga kafi ta Self Report, inda ban sani ba ko kana cikin waya kuma ka ji ATT CCG GTT CCG ABBB, ka sani, ko akwai wata dama da za ka iya samun wasika eValora consonant sauke nan ko can?
Halin ban dariya na labarin cewa wannan ko ta yaya prophylactic ne ko rigakafin kwari a gaban kashi ɗari na shaidun saboda shaidar ta nuna a sarari cewa babu wani ƙoƙarin da wani kamfani na magunguna ya yi don yaƙar cutar. Wannan yana game da samun mutane allurar da aka sani suna da cutarwa azaman furotin mai karu, don haka labarin murfin shine cewa idan kun sami bayanin furotin mai karu, zaku sami wasu nau'ikan taimako na gaba ɗaya.
Amma gaskiyar lamarin ita ce, ba a taɓa yin niyyar yi wa jama'a allurar rigakafi ba kamar yadda duniyar allurar rigakafi ta ayyana. Kuma yana da mahimmanci. Ina nufin, bari mu sake dubawa don rikodin kawai. Lokacin da Anthony Fauci yayi ƙoƙari sosai don samun wasu daga cikin nasa, faɗin, allurar rigakafin RNA da aka buga. Ya sa ofishin haƙƙin mallaka ya ƙi nasa haƙƙin mallaka. Kuma ina so in karanta abin da ofishin mallakar mallaka ya gaya masa lokacin da NIAID ta mallaki Anthony Fauci ya yi tunanin cewa zai iya samun MRNA kamar alurar riga kafi a matsayin rigakafin.
Kuma a nan ne maganar, "Wadannan muhawarar suna da rarrafe har zuwa cewa peptide na antigenic yana haifar da amsawar rigakafi wanda zai iya samar da kwayoyin da ke daure ga wani takamaiman peptide ko furotin, amma ba a yarda da shi ba game da maganin alurar riga kafi. Ok, wannan shine ofishin haƙƙin mallaka. Wannan ba wani nau'i ne na hukumar kiwon lafiyar jama'a ba, wannan shine ofishin mallakar mallaka, dole ne a samar da rigakafi fiye da yadda ake samar da maganin rigakafi.
Kamar yadda aka gani a cikin ofishin da ya gabata, aikin, fasaha ta gane kalmar maganin alurar riga kafi don zama fili wanda ke hana kamuwa da cuta. Mai neman bai nuna cewa nan take da'awar allurar rigakafin ta cika ko da ƙananan ma'auni da aka tsara a cikin ƙayyadaddun bayanai ba, balle ma'anar ma'anar aiki dangane da haka ya ce biyar, bakwai da tara ba sa aiki a matsayin rigakafin cutar HIV, wanda shine abin da yake aiki akai.
Shin ba mai amfani ba ne, don haka Anthony Fauci da kansa ofishin ikon mallakar ya gaya wa kansa cewa abin da yake ba da shawara a matsayin rigakafin bai dace da ma'aunin haƙƙin mallaka ba, ƙa'idar doka ko ƙa'idar asibiti?
Farfesa Martin Schwab- Oh. Za mu iya fassara wannan ga masu sauraronmu? Wannan yana iya zama da matuƙar muhimmanci.
Reiner- Wato, a taƙaice, David, shine abokinmu Martin. Farfesa Martin Schwab. Shi ne babban mai ba mu shawara kan harkokin shari'a daga Jami'ar Bielefeld.
Dauda - To, shikenan.
Reiner- Na san hakan, David. Na san da yawa daga cikin masu kallonmu sun yi mamaki kwarai da gaske. Na ga hakan daga amsoshin. Ɗaya daga cikin masu kallonmu ita ce ƙwararriyar gwajin PCR ɗinmu, Farfesa Camilla. Ba ta yarda da abin da ke faruwa a nan ba.
David- To, ga abin takaici da ban haushi, na taso da waɗannan batutuwa tun daga dubu biyu da biyu bayan fargabar cutar anthrax. Kuma abin takaicin shine yanzu muna zaune a cikin duniyar da muke da ɗaruruwan miliyoyin mutane waɗanda ake yi musu allurar kwamfuta mai motsa ƙwayoyin cuta, wanda ake sayarwa a ƙarƙashin abin da ofishin haƙƙin mallaka, abin da sana'ar likitanci take yi da kuma abin da FDA da ƙa'idodinta na asibiti suke yi.
Ba zai ba da shawarar rigakafin ba, amma ta amfani da kalmar. A yanzu muna fuskantar ɗaruruwan miliyoyin mutane. Ga abin da aka sani da dubu biyu da biyar, makamin halitta. Don haka na ga akwai daruruwan sa'o'i na wannan kayan da aka sadaukar don tunawa saboda na yi shekaru ashirin, amma idan kuna da wasu tambayoyi, zan yi farin cikin amsa su a can.
Reiner- Na tabbata za su yi tambayoyi da yawa, David. Za mu tuntube ka. Ina tsammanin mutane za su cika ka da tambayoyi, ta hanyar imel na mutane, da sauransu. Zan gabatar da abin da ya shigo ko kuma mu gabatar da abin da ya shigo. Amma ina tsammani. Amma oh, eh, muna da Martin Schwab. Wataƙila yana da tambaya mai mahimmanci.
Martin- Na duba lambar majiyyaci ta biyu, wanne ne? An shigar da 722O852, da 7151163, da 722O8521 a ranar 12 ga Afrilu, kuma an shigar da 715 haka nan aka shigar a ranar 28 ga Afrilu, 2004. Na ga bambanci tsakanin goma sha shida, ba kwana uku ba. Me na fahimta ba daidai ba?
David- Afrilu 23, 2003 shine ranar da aka shigar da ƙarar babban jami'in CDC.
Martin- To, ya yi kyau.
Reiner- Na san Dr. Phil Mash yana da cikakken bayanin a cikin fayil ɗin Fauci. 100% na wannan bayanin yana cikinsa. Ƙarin bayanin da na aika a duk yana da bayanan a ciki, gami da duk ranakun da aka fi mayar da hankali kan shigar da bayanai da kuma ranar fitowa. Don haka 100% na wannan yana cikin bayanan da aka buga a rubuce kuma kuna da bayanan da aka rubuta.
Martin- Ok.
Reiner- Na ƙirƙiri fayil ɗina kuma an yi masa lakabi da David Martin.
Martin- To, to. Akwai wani bincike da na yi kan rahotannin kafofin watsa labarai a nan. Zan iya tabbatar da cewa suna ba da labarin gefe ɗaya game da annobar. Duk wanda ya kuskura ya ayyana barazanar ba ta da haɗari kamar gwamnati za a yi masa Allah wadai da ita a matsayin masu ra'ayin makirci, tinfoil da sauransu. Kun sani, don haka kafofin watsa labarai sun yi abin da kuka nuna a cikin jumlar. Kuna maimaita ta sau biyu a baya. A'a, a zahiri, suna ba mu labarin bambancin Delta, wanda aka ce ya fi yaɗuwa, fiye da duk wani abu. Masana da na yi magana da su sun gaya mini cewa bayanan sun ƙunshi nau'ikan har guda dubu arba'in.
Dauda - To, shikenan.
Martin- Shin wannan nau'in Delta zai iya zama wani irin tallan kafofin watsa labarai da ka gaya mana a can?
Dauda- Babu wani abu kamar alpha ko beta ko Gamma Delta. Wannan hanya ce da abin da ake nema da matuƙar wahala shine matakin da za a iya tilasta wa mutane su karɓi wani abu da ba za su yarda da shi ba. Babu wani bincike da aka buga kan abin da aka ruwaito cewa shi ne Delta variant. Ba a ƙididdige yawan jama'a ba, wanda shine ainihin adadin kwafi, abin da aka kiyasta shine kwaikwayon kwamfuta.
Amma abin takaici, idan ka duba GSGIS AID, wanda shine tushen jama'a na loda kowane ɗayan nau'ikan bambance-bambancen, abin da za ku samu shine cewa ba a sami ikon gano duk wani tsarin kwayoyin halittar da aka canza a asibiti ba, wanda sannan ya bayyana bambancin asibiti. Kuma wannan ita ce matsalar gaba ɗaya. Wannan ita ce matsalar. Komawa farkon abin da ake zargin ya zama annoba shine ba mu da wata shaida cewa canjin tsarin kwayoyin halitta yana da wani mahimmanci na asibiti ko yaya.
Babu wata takarda da wani ya buga wanda a zahiri ya tabbatar da cewa wani abu na labari tun watan Nuwamba na ashirin da tara na sha tara yana da banbancin asibiti daga duk wani abu da ya gabata Nuwamba ashirin da sha tara. Matsalar haƙƙin haƙƙin mallaka guda saba’in da uku da na kwatanta shi ne waɗannan haƙƙin mallaka na saba’in da uku duk sun ƙunshi abin da aka ruwaito na labari ne. A watan Disamba da Janairu na ashirin da sha tara da ashirin da ashirin, bi da bi.
Don haka matsalar ita ce, ko da za mu yarda cewa akwai ciwon huhu na idiopathic, ko da za mu yarda cewa akwai wasu alamomin da ke haifar da cututtuka. Ba mu da guda ɗaya na shaidar da aka buga wanda ke gaya mana cewa wani abu game da sub sars-cov-2 yana da bambanci na asibiti daga duk wani abu da aka sani kuma aka buga kafin Nuwamba. Ashirin da tara a cikin 73 haƙƙin mallaka wanda ya kai dubu biyu da takwas.
Viviane- Amma shin zai iya zama cewa bambancin Delta shine kawai bambance-bambancen, kun sani, cewa alamun asibiti iri ɗaya ne, amma yana da, kun sani, ikon, kamar, kamuwa da cutar ga wanda ya riga ya kamu, kamar Variant B beta.
David- To, a nan ne muke ganin yawan martani da kuma ɗabi'ar da ake nunawa ga masu yaɗa labarai. Babu kuma zan maimaita wannan, babu wata shaida da ke nuna cewa bambancin Delta ya bambanta da wani abu banda gaskiyar cewa yanzu muna neman abu ba yana nufin cewa abu ne ba domin muna kallon gutsuttsuran abubuwa. Kuma gaskiyar magana ita ce idan muka zaɓi wani gutsuttsuran da zan iya ƙirƙirawa, kun sani, zan iya ƙirƙirar Variant Omega gobe.
Martin- Haka ne.
David- Kuma zan iya samun Variant Omega kuma zan iya cewa ina neman wannan ƙaramin sinadari na DNA ko RNA ko ma furotin. Kuma zan iya gudu a duniya ina tafiya, kai, Allahna, ina jin tsoron bambancin omega.
Martin- Haka ne.
Dauda- Kuma matsalar ita ce saboda yanayin yadda muke tsara kwayoyin halitta a halin yanzu, wanda a zahiri tsari ne na haɗa abubuwa, shine abin da muke kira a lissafi da kuma haɗa abubuwa, ba mu da wani ma'ana da za mu iya sani ko abin da muke kallo ya bambanta ko dai daga ma'anar asibiti ko ma ta kwayoyin halitta.
Don haka muna cikin tarko a cikin duniyar da, abin takaici, idan ka je ka duba, kamar yadda na yi a cikin takardun da suka keɓe bambance-bambancen Delta kuma a zahiri na yi tambaya, shin bambance-bambancen Delta wani abu ne ban da zaɓin jeri a cikin tsari na tsari na wani tsarin da aka riga aka bayyana? Amsar ita ce kawai canji. Kuma lokacin da kuka fara da dakatar da abin da kuke kira firam ɗin karatu. Babu novel komai
Reiner- Dr. Wolfgang ya yi imanin cewa haƙƙin mallaka yana da matsala ƙwarai domin ya bayyana cewa wataƙila ya ninka tsadar magungunan mallaka sau biyar, maimakon samun magungunan gwamnati, ba na gwamnati ba, amma jami'o'in gwamnati suna samun kuɗin da suke buƙata don samar da waɗannan alluran rigakafi.
Dauda- Eh, bari in yi wani abu da ba shi da adalci sosai, amma zan riƙe takardar kusa da allon kuma don dalilai ne kawai na wakilci. Amma ina so ku ga cewa wannan shine Baric Patent da NIH ta buƙaci ta mayar musu saboda dalilai masu ban mamaki a cikin ashirin da goma sha takwas. Wannan shine bakwai zuwa bakwai tara uku bakwai. Kuma mutane za su iya duba wannan da kansu.
Amma idan a zahiri ka kalli jerin abubuwan da aka ba da izini, wanda yana ɗaya daga cikin abubuwan da muka yi, a zahiri za mu kalli jerin abubuwan da aka buga kuma mu gane cewa ya danganta da inda kuka ɗora ainihin kirtani na jeri, za ku sami abu iri ɗaya ko kuma kuna da wani abu na daban ba tare da wani abu ba face a inda kuka yanke shawarar wuce faifan. Kuma ina son karanta muku.
Ina nufin, wannan wani abu ne da ya zo kai tsaye daga aikace-aikacen haƙƙin mallaka lokacin da suke magana a zahiri game da igiyoyin DNA, waɗanda suke kiran lambobin ID na jerin, a zahiri sun ce kwayoyin halitta wani tsari ne na wucin gadi. Jeri na wucin gadi yana nufin cewa ba jerin ba ne wanda ke da ka'ida ta asali. Ba wani abu ba ne wanda ya bayyana don takamaiman furotin na halitta ko tsarin RNA na halitta wanda aka keɓe.
Kowane ɗayan waɗannan, a haƙiƙa, jeri ne na wucin gadi na roba. Idan kuma ka koma ka duba kowanne daya daga cikinsu, wanda muka yi, abin da za ka samu shi ne, jerin abubuwan, a zahiri, suna ci gaba a lokuta da dama, amma suna tafe ne a wasu inda kawai kaddara Caprice ce ta ce wani abu ko ba ya cikin budaddiyar firam ɗin karatu ko kuma yana ko ba ya cikin jerin abubuwan Ilagan nucleotide.
Yanzu, dalilin da ya sa hakan ke da mahimmanci shine domin idan za mu bincika abin da a ƙarshe ake yi wa mutane allura, muna buƙatar ainihin jerin abubuwa, ba nau'in kama da muke buƙatar ainihin jerin ba. Kuma idan kun kalli abin da FDA ke buƙata kuma idan kun kalli yanayin ƙa'idodin ƙa'idodin Turai kuma idan kun kalli sauran yanayin ƙa'idodin ƙa'idodin duniya don dalilai waɗanda ba za a iya bayyana ainihin jerin abubuwan da suka shiga cikin abin da aka ƙarawa a cikin alluran da alama ba su da wahala.
Yana da alama wani abu ne da wani ba zai iya ba, a zahiri, ya bayyana da tabbaci dari bisa dari. Matsala ita ce X. Matsalar da ke nunawa ita ce, a wannan lokaci, kamar yadda za a iya gaya mana cewa, ka sani, gwaje-gwaje na asibiti da ke faruwa kuma akwai wasu abubuwa da ke faruwa. Ba mu da wata hanya ta tabbatar da cewa cikakken jerin an kasance, ko ana iya ƙera shi a cikin abin da a ƙarshe ya zama nanoparticle na lipid wanda shine mitar mai ɗaukar allura a ciki.
Kuma yana da kyau mutane su fahimci cewa tun daga shekara ta 2002 zuwa 2003 da takardar shaidar mallaka na shekarar 2008 da kuma takardar shaidar mallakar makami da aka fara a shekara ta XNUMX, a kowane ɗayan waɗannan lokuta, an gano guntu, amma an gano su ba tare da takamaiman bayani ba. Don haka ba mu da ƙarshen ƙarshen ɓangarorin kai tsaye. Muna da gutsuttsura waɗanda ke da, ka sani, ainihin gibin da za a iya sanyawa a ciki.
Kuma wannan shine dalilin da ya sa na ga gaskiyar yin la'akari da yanayin haƙƙin mallaka ya zama mafi ban takaici, saboda dalilin da ya sa masu binciken gaskiya a cikin halayen su na kasala, dalilin da ya sa masu binciken gaskiya ba su bincikar gaskiya ba idan aka zo batun haƙƙin mallaka shine saboda ainihin jerin ba a wakilta a cikin nau'i na dijital wanda ya sa ya zama sauƙi don yin wannan kwatanta. A zahiri dole ne mu ɗauki hotunan takarda da aka ƙaddamar sannan mu rubuta waɗanda ke ciki don yin namu kima.
Ba za ku iya yin wannan akan rukunin haƙƙin mallaka na EPOs ba. Ba za ku iya yin wannan tare da bayanan YPO daga Geneva ba. Ba za ku iya yin wannan tare da bayanan Ofishin Ba da Lamuni na Amurka ba. A zahiri dole ne ku shiga kuma ku sake gina ainihin jerin kwayoyin halitta da hannu sannan ku kwatanta su da abin da aka ɗora akan sabar jama'a. Kuma a nan ne za ka ga cewa batun sabon abu abu ne da ba a magance shi ba. Wannan ruɗi ne da aka ƙera.
Wolfgang- Ina da wata tambaya guda ɗaya. Shin zai yiwu mu ga cewa mura ta ɓace, ta ɓace? Ba mu da mura kuma? Mura tabbas ita ce kwayar cutar ma an tsara ta. Kuma shin zai yiwu waɗannan jerin abubuwan da muke magana a kai yanzu, cewa suna iya wanzuwa a cikin nau'ikan ƙwayoyin cuta guda biyu don haka kawai batun gwaji ne da kayan aiki don lura da abin da muka samu, ko mun sami mura ko mun sami koruna? Idan muna da takamaiman idan kuna da littafi, kuna da kalma mai haruffa biyar. Koma dai mene ne, akwai haruffa biyar a cikin littattafai da yawa.
Dauda- Haka ne, daidai.
Wolfgang- Haka ne.
David- Eh Wolfgang, tambayarka kyakkyawar misali ce ta ainihin matsalar. Matsalar ita ce idan abin da muke nema wani abu ne da muka yanke shawarar cewa ya cancanci a nema, to za mu same shi. Kuma labari mai daɗi shine za mu same shi a wurare da yawa. Kuma idan muka yanke shawarar cewa ba ma neman wani abu, ba abin mamaki ba ne cewa ba ma samunsa domin ba ma nemansa.
Gaskiyar lamarin ita ce, ko gwaje-gwajen RTPCR ne muka yanke shawarar cewa akwai gutsuttsura waɗanda, ta hanya, na duba kowane ɗayan abubuwan da aka gabatar. An ƙaddamar da hakan ga FDA don ƙoƙarin gano menene ma'aunin zinare don samun izinin amfani da gaggawa da kuma wane guntu sars-cov-2 a hukumance shine guntun hukuma wanda shine ma'aunin kwatanta.
Kuma matsalar ita ce ba za ku iya samun ma'auni ɗaya ba. Don haka tambayar ta zama, a cikin duniyar da babu ma'auni guda ɗaya, menene ainihin abin da kuke samu? Domin idan ina nema kuma me yasa bazan karanta wannan ba, idan ina neman CCACGCTTTG, zan ƙara layin G na gaba ko in tafi, a'a, a'a, a'a. Abu na gaba shine GTTTAGTTCG. Kuma kun fahimci batun. Maganar ita ce inda na zabi farawa da tsayawa.
A gaskiya zan iya cewa na samo shi, oh ban same shi a nan ba kuma ban sami ashana da na zayyana a kan bayanan ba saboda na zabi in kalli bayanan ta hanyar da ban sami wasan ba. Mura ba ta bar yawan mutane ba. Mura ta kasance kasa shekaru goma dogon kwanon rufi umarnin rigakafin mura wanda aka matsananciyar, matsananciyar, matsananciyar ciyar da gwamnatoci a duniya, sun kasa kuma suka yanke shawarar idan mura ba ya sadar da jama'a alƙawarin samun kowa da kowa don samun allura, bari mu canza pathogen.
Wolfgang - Akwai wasu da yawa, suna iya canzawa.
Dauda- Allah, muna da abubuwa da yawa da za mu yi nan gaba,
Reiner- Amma yanzu mun fara da su.
Viviane- Ina so in gaya muku wani abu game da wannan ci gaban gwajin Drosten PCR, kun sani, domin mun duba shi. Ina nufin, a takaice, ba wai har yanzu kun duba haƙƙin mallaka da kuka bayyana ba, amma mun duba wannan irin mu'ujiza ko kuma kamar ina nufin, wani ɓangare mai ban mamaki kamar ci gaban gwajin Drosten, domin a nan Indiya.
Duk da cewa zai buƙaci ta hanyar ma'aikacin sa, sadaka za ta sami damar riƙe haƙƙin mallaka akan wannan, ka sani, ƙirarsa. Kawai ya buga umarnin su ma kowa na iya gani. Don haka a zahiri duk abin da aka ƙirƙira ya ɓace, kun sani, yuwuwar samun haƙƙin mallaka. Kuma wannan wani nau'i ne na ban mamaki, ka sani, idan ka duba.
Don haka mun tambayi wannan a cikin buƙatun Dokar 'Yancin Bayanai. Don haka suka ce, to ka sani, domin an yi gaggawar ganin an yi gwajin cutar saboda ana fama da wannan annoba. Don haka ya zama kamar ba mu duba kudi ba, ka sani, ba mu damu ba. Don haka wannan baƙon abu ne a matsayin hanya domin, Ina nufin, a zahiri, wannan gwajin kalmomi ne masu daraja kamar biliyoyin.
Ka sani, ta yaya za ku iya kawai, ina nufin, wannan asibiti ne da ake ba da kuɗin jama'a. Ta yaya za su ba ka, ka sani, ba da duk wannan duka? Sannan kuma saboda shima yana da hadin gwiwa da wani kamfani mai zaman kansa, Tip Mobule, haka ma ya kirkiro dukkan gwaje-gwajen tun daga shekarar 2002, daga SARS na farko sai kuma MEARS da sauransu.
Don haka yana da ban mamaki, ka sani, domin ya kasance kamar yana aiki a matsayin mai buɗe kofa na wannan kamfani, ka sani, saboda su ma sun ce mana. Don haka m shi ne kofa mutum ya yanke shawarar abin da zai yiwu kasa ko kamar dakin gwaje-gwaje ko duk abin da gwajin, wannan TIP Mobule kamfanin zai aika fitar da gwajin kits domin sa'an nan, ba shakka, samun karin kudi, domin ya kasance m kamar ya na da farko moro amfani, ka sani, amince da kuma ko wannan kamfani.
Don haka a bayyane yake yanzu, ina nufin, watakila babu wani abu a wancan lokacin saboda an riga an riga an yi haƙƙin mallaka da yawa. Don haka a zahiri daga wannan ba sabon ƙwayar cuta ko gwajin PCR ba, ba zai iya ba da izinin wani abu da zai zama sabo ba. Don haka a zahiri ya kasance kamar abu mai ma'ana da za a yi sannan a yi amfani da duka abu a matsayin kawai don yin, ka sani, samun riba daga wannan fa'idar mai motsi na farko kuma watakila kawai yana da hannu cikin wannan tsarin doka.
Reiner- yana ɗaya daga cikin manyan mutane a cikin wannan shirin, domin shi ne wanda suka fara jan igiyoyinsa.
Dauda- Eh, kana buƙatar ƙirƙirar mafarkin buƙata. Kuma babu wani abu da ya fi yin aiki mafi kyau na ƙirƙirar mafarkin buƙata fiye da gaggawar wani abu da ka ƙirƙira.
Reiner - Wannan yana kama da barkwanci, amma ba haka bane.
Dauda- To, a cikin wannan ne ya kamata mu fahimci cewa wani ɓangare na dalilin da ya sa ya kasance da sauƙi a gare mu mu sa ido da bin diddigin wannan, kun sani, kamfen na tilastawa da ta'addanci, shine saboda mun taɓa yin hakan a baya. Kun sani, na fara tsokacina ta hanyar tabbatar da cewa mutane suna tuna hakan lokacin da ake maganar magance barkewar cutar anthrax. Yanzu, ku tuna cewa yayin da muke da ɗaruruwan dubban sojoji a Gabas ta Tsakiya da ake zargin sun rama abubuwan da suka faru a watan Satumba na 2001.
Muna da masu duba akwatin gidan waya guda biyu suna binciken anthrax, biyu mafi girma da ake zargi da kai harin makamin halittu a ƙasar Amurka. Kuma muna da masu duba gidan waya guda biyu. Ba za ku iya yarda da gaske ba cewa masu duba akwatin gidan waya guda biyu sune, kun sani, laifin tsayawa, kun sani. Hankali-, mutane masu ƙarfi a sararin samaniya yanzu, ba ni da wani abu game da masu duba gidan waya, amma zan iya ba ku tabbacin cewa idan ina binciken harin ta'addanci.
Ba zan sami ofishin gidan waya yana da masu duba akwatin gidan waya guda biyu a matsayin ƙwararrun ƙwararrunsu suna gudanar da bincike ba. Ka sani, abin ba daidai ba ne kuma Majalisa ta san shi. Kuma wannan shi ne dalilin da ya sa muke buga wani abu wanda ba lallai ba ne ya zama mafi kyawun siyarwa, amma muna buga bayanan sirri game da duk wani keta yarjejeniyar makamai masu guba da mutane suka sanya hannu a duniya. Kuma littafin waya ne da ke ba da labarin inda da wane da kuma wanda ke ba da kuɗi.
Don haka a gare mu, bai yi wuya a gane cewa wannan ba matsalar lafiyar jama'a ba ce. Wannan kamfen ɗin talla ne mai dama don magance wata manufa da aka bayyana. Kuma shi ya sa wannan shi ne reza Occam. Abu mafi sauki a siffanta shi ne domin su ne suka kafa shi. Kuma gaskiyar reza ta Occam ita ce sun ce suna buƙatar samun jama'a su karɓi maganin rigakafin ƙwayar cuta na coronavirus kuma suna buƙatar kafofin watsa labarai don ƙirƙirar haɓaka kuma masu saka hannun jari za su bi inda suka ga riba.
Ba ku da wani abin da kuke buƙatar dogara da shi don bayyana abubuwan da suka faru a cikin watanni 20 da suka gabata, sannan ainihin bayanin wanda ya aikata laifin. Kuma ba na yin aikin kallon cibiya na shiga don ƙoƙarin fahimtar ko akwai batutuwan momy a bayan ɗan fashin banki. Idan suna rike da jakar kudi a wajen banki. A gaskiya na yi hauka zaton cewa watakila su 'yan fashin banki ne.
Hakazalika, idan ina da wanda ya ce muna bukatar mu yi amfani da kafofin watsa labarai don yin tallan kayan aikin likita na karfe, wanda shine ainihin allurar da aka yi da simintin gyare-gyaren simintin gyare-gyare ta hanyar kwamfuta, idan da gaske zan saurari dalilin da ya sa za a iya yin hakan, zan saurari wanda ke yin magudin da ya ce masu zuba jari za su bi inda suka ga riba. Ni ma bana bukatar karin bayani.
Reiner- To, wannan abin mamaki ne. Ina matukar farin ciki, David, da muka yi magana watanni biyu da suka gabata, wataƙila watanni uku, uku, huɗu da suka wuce, kuma wani David ya gabatar da mu ga juna. Yi haƙuri, James Henry.
Dauda- Dama.
Reiner- Kuma ina ƙoƙarin nemo lauyoyin haƙƙin mallaka a wannan ƙasar waɗanda za su iya sha'awar wannan shari'ar. Yanzu, akwai lauyoyin haƙƙin mallaka kaɗan waɗanda suka fahimci hakan, amma babu wanda ya san hakan har zuwa yanzu. Amma wataƙila wannan zai canza. Amma babu wanda ya yarda ya magance wannan a cikin mahallin Corona, wannan ita ce matsalar.
Wolfgang- Amma wannan ba sabon abu bane. Na yi ƙoƙarin nemo irin wannan lauya don ya ƙware a fannin ƙwarewa a kwamitin Bundestag na Jamus. Don haka shekaru 10 da suka wuce fiye da shekaru 15 da suka gabata. Kuma ba mu same shi ba saboda duk suna jin tsoron sukar tsarin.
Dauda - eh.
Wolfgang - za su yi za su lalata aikinsu. Yana da matuƙar wahala.
David- Eh, ka tuna cewa wannan tsohuwar matsala ce domin a nan ne matsalar ta fara. Tun lokacin da aka kafa Ofishin Patent na Turai, Jamusawa da Faransawa, ba abin mamaki ba ne, sun ci gaba da nuna ƙiyayya wanda shine sabon nau'in ƙiyayya da ta faru tun ƙarni da yawa. Amma lokacin da aka kafa EPO, rawar da ofishin patent a Munich ya taka a matsayin batun ƙasa ga Jamus.
Kuma ra'ayin cewa masu binciken haƙƙin mallaka na Jamus da ƙwararrun ƙwararrun haƙƙin mallaka na Jamus har yanzu suna jin daɗin ɗaukaka a kan sauran ƙasashen Turai ya zama akida a cikin 2003 da 2004 lokacin da ƙungiyar ta fara tantance ofishin haƙƙin mallaka na Turai kuma inda muka nuna cewa a wani wuri tsakanin kashi 20 zuwa 30 cikin XNUMX na haƙƙin mallaka a Turai na aiki ne na jabu, ma'ana an kwafi su daga takardun shaida na baya-bayan nan na Jamus.
Ƙasar ofishin kula da haƙƙin mallaka na Turai sun bace da tunanin cewa suna yin wani abu da ba daidai ba ne lokacin da Tarayyar Turai ta umurce mu da yin gwajin haƙƙin mallaka na software bayan ƴan shekaru, bisa buƙatar tawagar Sweden zuwa Tarayyar Turai. Kuma mun nuna ɗaruruwa da ɗaruruwan haƙƙin software waɗanda Tarayyar Turai ta ba su ba bisa ka'ida ba ta hanyar EPO. Sannan kuma mun gano cewa Jamusawa ne masu yin jarrabawar haƙƙin mallaka da kuma masu aikin haƙƙin mallaka na Jamus waɗanda ke da alhakin shigar da su.
Mun sake ganin cewa an yi kururuwa mai yawa. Don haka abin da ya faru shi ne cewa muna da matsayi na akida wanda ke cewa duk da cewa ofishin kula da haƙƙin mallaka na Turai ya kamata ya zama na ƙasashen Turai, har yanzu akwai a cikin tunanin kafa ikon mallakar Jamusanci, fifiko kan sauran ƙasashen Turai. Kuma idan kun yi tambaya game da wani abu, gami da haƙƙin mallaka da aka bayar akan wani makamin bioweapon, kuna taka ƙasa wanda babu gafara.
Wolfgang- Eh, mun yi wasu tambayoyi daga Transparency International kuma mun ɓace. Ba a bi batun ba.
Dauda- Eh. To, ba za ka iya ba, ba haka ba ne, ba za a iya isa gare shi ba. Kuma wannan shine kawai abin da ya faru na abin da ya zama ƙungiyar kama mutane. A zahiri ba ta yin hidimar jama'a ba ce. Na gode da lokacin da ka ɓata. Kuma ina fatan hakan ya taimaka.
Reiner- Ina tsammanin ya taimaka sosai.
Wolfgang - Na gode sosai.
Reiner - Za mu ji ƙararrawa da yawa. Na gode, David, kuma ina yi muku kyakkyawan karshen mako.
David- To, ku kula, kowa da kowa.
Reiner- Kai ma. Sai anjima, sai anjima.
Dauda- Sai anjima, sai anjima.
###
Yi wa abokanka, danginka da abokan aikinka alheri don tabbatar da cewa sun kasance masu wayo na Sino:
LATSA, TV da RADIO
Akai na: https://radiosinoland.com/about-the-author/
Bidiyon Bichute: https://www.bitchute.com/channel/REzt6xmcmCX1/
Littattafai: https://radiosinoland.com/2018/06/18/praise-for-the-china-trilogy-the-votes-are-in-it-r-o-c-k-s-what-are-you-waiting-for/
Bidiyon Brighteon: https://www.brighteon.com/channels/jeffjbrown
itunes: https://itunes.apple.com/cn/podcast/44-days-radio-sinoland/id1018764065?l=en
Ivoox: https://us.ivoox.com/es/podcast-44-days-radio-sinoland_sq_f1235539_1.html
Labari: https://radiosinoland.com/blog-2/
Dalili.fm: https://reason.fm/podcast/china-rising-radio-sinoland-fluNNZY68
RUvid: https://ruvid.net/w/radio+sinoland
Sautin Cloud: https://soundcloud.com/44-days
Stitcher Radio: http://www.stitcher.com/podcast/44-days-publishing-jeff-j-brown/radio-sinoland?refid=stpr
YouTube: https://www.youtube.com/channel/UCS4h04KASXUQdMLQObRSCNA
Sautin Vurbl: https://vurbl.com/station/1Vc6XpwEWbe/
Shafukan yanar gizo: http://www.chinarising.puntopress.com ; www.bioweapontruth.com ; www.chinatechnewsflash.com
Social Media
email: [email kariya]
Facebook: https://www.facebook.com/44DaysPublishing
Mai Girma: https://www.flickr.com/photos/98158626@N07/
Getr: https://gettr.com/user/44_days
Instagram: https://www.instagram.com/jeffjbrown_44days/
Layin App/Waya/Signal/Telegram/WhatsApp: +33-6-12458821
Linkedin: https://cn.linkedin.com/in/jeff-j-brown-0517477
Pinterest: https://www.pinterest.com/jeffjb/
Parler: https://parler.com/profile/jeffjbrown
Sinawa: http://weibo.com/u/5859194018
Skype: live:.cid.de32643991a81e13
Tumblr: http://jjbzaibeijing.tumblr.com/
Twitter: https://twitter.com/44_Days
VK: http://vk.com/chinarisingradiosinoland
WeChat: + 86-19806711824
Me ya sa kuma yadda kasar Sin ke aiki: Tare da madubi zuwa Tarihinmu
JEFF J. BROWN, Edita, Tashin China, kuma Babban Editan & Wakilin China, Aiko daga Beijing, The Greanville Post
Jeff J. Brown masanin nazarin yanayin ƙasa ne, ɗan jarida, malami kuma marubucin The China Trilogy . Ya ƙunshi kwanaki 44 na Backpacking a China – The Middle Kingdom in the 21st Century, tare da Amurka, Turai da Fate of the World in Its Looking Glass (2013); Punto Press ta fitar da China Rising – Capitalist Roads, Socialist Destinations (2016); da kuma BIG Red Book on China (2020). Haka kuma, ya buga littafin karatu, Treasure Trove to Great English na Doctor WriteRead (2015). Jeff babban Edita ne kuma Wakilin China ga The Greanville Post , inda yake riƙe da shafi, Dispatch daga Beijing kuma Shugaban Ra'ayin Duniya ne a ƙarni na 21. Hakanan yana rubuta shafi ga The Saker , wanda ake kira Moscow-Beijing Express . Jeff yana rubutu, yana yin tambayoyi da podcasts akan shirinsa, China Rising Radio Sinoland , wanda kuma ana samunsa a YouTube , Stitcher Radio , iTunes, Ivoox da RUvid . Baƙi sun haɗa da Ramsey Clark , James Bradley , Moti Nissani , Godfree Roberts , Hiroyuki Hamada , The Saker da sauransu da yawa.
Ana iya samun Jeff a China Rising , [email protected] , Facebook , Twitter , Wechat (+86-19806711824/Mr_Professor_Brown, da Layi/Signal/Telegram/Whatsapp: +33-612458821.
Karanta shi cikin harshenku • Lealo en su idioma • Lisez-le dans votre langue • Lies es in deniner Sprache • Прочитайte это на вашem яzyke • 用你的语言阅读
[google-translator]
Rukunin Wechat: bincika lambar waya +8619806711824 ko ID dina, Mista_Professor_Brown, buƙatar abokina kuma ka nemi Jeff ya shiga rukunin Wechat na Sinoland Rediyon Sinoland. Zai ƙara ku a matsayin memba, don ku iya shiga cikin tattaunawar da ke gudana.
Ina ba da gudummawa ga